174 related articles for article (PubMed ID: 33330078)
1. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas.
Kuranari Y; Tamura R; Tsuda N; Kosugi K; Morimoto Y; Yoshida K; Toda M
Front Oncol; 2020; 10():592470. PubMed ID: 33330078
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
3. Association between preoperative hematologic markers and aggressive behavior in meningiomas.
Guidry BS; Chotai S; Tang AR; Le CH; Grisham CJ; McDermott JR; Kelly PD; Morone PJ; Thompson RC; Chambless LB
Clin Neurol Neurosurg; 2023 Mar; 226():107629. PubMed ID: 36822137
[TBL] [Abstract][Full Text] [Related]
4. Radiomic signatures of meningiomas using the Ki-67 proliferation index as a prognostic marker of clinical outcomes.
Khanna O; Fathi Kazerooni A; Arif S; Mahtabfar A; Momin AA; Andrews CE; Hafazalla K; Baldassari MP; Velagapudi L; Garcia JA; Sako C; Farrell CJ; Evans JJ; Judy KD; Andrews DW; Flanders AE; Shi W; Davatzikos C
Neurosurg Focus; 2023 Jun; 54(6):E17. PubMed ID: 37552657
[TBL] [Abstract][Full Text] [Related]
5. A Clinical Prognostic Model Based on Preoperative Hematological and Clinical Parameters Predicts the Progression of Primary WHO Grade II Meningioma.
Gao P; Kong T; Zhu X; Zhen Y; Li H; Chen D; Yuan S; Zhang D; Jiao H; Li X; Yan D
Front Oncol; 2021; 11():748586. PubMed ID: 34707993
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.
Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B
World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940
[TBL] [Abstract][Full Text] [Related]
7. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors, Survival, and Treatment for Intracranial World Health Organization Grade II Chordoid Meningiomas and Clear-Cell Meningiomas.
Zhang GJ; Zhang YS; Zhang GB; Yan XJ; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Sep; 117():e57-e66. PubMed ID: 29859361
[TBL] [Abstract][Full Text] [Related]
9. WHO grade II and III meningiomas: a study of prognostic factors.
Durand A; Labrousse F; Jouvet A; Bauchet L; Kalamaridès M; Menei P; Deruty R; Moreau JJ; Fèvre-Montange M; Guyotat J
J Neurooncol; 2009 Dec; 95(3):367-375. PubMed ID: 19562258
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Prognostic Factors of World Health Organization Grade Ⅲ Meningiomas.
Tian W; Liu J; Zhao K; Wang J; Jiang W; Shu K; Lei T
Front Oncol; 2020; 10():593073. PubMed ID: 33425743
[TBL] [Abstract][Full Text] [Related]
11. WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.
Ressel A; Fichte S; Brodhun M; Rosahl SK; Gerlach R
J Neurooncol; 2019 Nov; 145(2):277-286. PubMed ID: 31578671
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
13. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
Oya S; Kawai K; Nakatomi H; Saito N
J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-Lymphocyte Ratio and Its Changes are Related to Grade II-IV Glioma Recurrence.
Ma L; Li G; Wei M
Cancer Manag Res; 2020; 12():9429-9434. PubMed ID: 33061630
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Clinical Outcome of First Recurrence Skull Base Meningiomas.
Kuranari Y; Tamura R; Tsuda N; Kosugi K; Morimoto Y; Yoshida K; Toda M
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31906133
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
17. Low Transforming Growth Factor-β3 Expression Predicts Tumor Malignancy in Meningiomas.
Ma J; Li D; Chen Y; Zhang Y; Song L; Tian K; Yang Y; Chen L; Weng J; Cao X; Hao S; Wang L; Wu Z; Zhang J
World Neurosurg; 2019 May; 125():e353-e360. PubMed ID: 30703597
[TBL] [Abstract][Full Text] [Related]
18. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
Sá-Marta E; Alves JL; Rebelo O; Barbosa M
World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
[TBL] [Abstract][Full Text] [Related]
19. Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.
Savardekar AR; Patra DP; Bir S; Thakur JD; Mohammed N; Bollam P; Georgescu MM; Nanda A
World Neurosurg; 2018 Apr; 112():e74-e83. PubMed ID: 29258946
[TBL] [Abstract][Full Text] [Related]
20. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
Korshunov A; Shishkina L; Golanov A
Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
